Page last updated: 2024-10-31

mirtazapine and Thoracic Neoplasms

mirtazapine has been researched along with Thoracic Neoplasms in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kinomura, M1
Iihara, H1
Fujii, H1
Hirose, C1
Endo, J1
Yanase, K1
Inui, T1
Kaito, D1
Sasaki, Y1
Gomyo, T1
Sakai-Masuda, C1
Kawae, D1
Kitamura, YU1
Fukui, M1
Kobayashi, R1
Ohno, Y1
Suzuki, A1

Other Studies

1 other study available for mirtazapine and Thoracic Neoplasms

ArticleYear
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
    Anticancer research, 2023, Volume: 43, Issue:3

    Topics: Antiemetics; Carboplatin; Humans; Mirtazapine; Nausea; Platinum; Retrospective Studies; Serotonin; T

2023